Manufacturer record
Chimak Health Care: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Chimak Health Care (Himachal Pradesh) were declared Not of Standard Quality between August 2025 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Chimak Health Care in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol and Tramadol Hydrochloride Tablets IP | LBHK25001Mfg 2025-02 · Exp 2028-01 | The Sample does not conform to IP Standards with respect to Dissolution.Dissolution | DTL ThrissurState lab | Feb 2026 |
| Paracetamol and Tramadol Hydrochloride Tablets IP | LBHK25001Mfg 2025-02 · Exp 2028-01 | The sample does not conform to IP Standards with respect to Dissolution.Dissolution | DTL ThrissurState lab | Nov 2025 |
| Lorazepam Tablets | LALO24014Mfg 2024-11 · Exp 2027-10 | Dissolution test and Assay for LorazepamAssay | KarnatakaState lab | Aug 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.